AGRX Agile Therapeutics Inc.

4.88
+0.03  (1%)
Previous Close 4.85
Open 4.88
Price To book 4.00
Market Cap 166829349
Shares 34,186,342
Volume 113,136
Short Ratio 1.28
Av. Daily Volume 229,083

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171179843
  2. 8-K - Current report 171179748
  3. 8-K - Current report 171174703
  4. 8-K - Current report 171139463
  5. 8-K - Current report 171128878

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued 2013. Phase 3 top-line data released January 3, 2017 - poor data. NDA resubmitted with PDUFA date of December 26, 2017
Twirla
Contraceptive patch

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171179843
  2. 8-K - Current report 171179748
  3. 8-K - Current report 171174703
  4. 8-K - Current report 171139463
  5. 8-K - Current report 171128878
  6. 8-K - Current report 171111827
  7. 8-K - Current report 171081417
  8. SC 13G - Statement of acquisition of beneficial ownership by individuals 171040948
  9. SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals 171007889
  10. 8-K - Current report 171005402